Questions and answers

ESC Premium Access

Questions and answers

Session: Improving outcomes with non-vitamin K antagonist oral anticoagulants (NOACs): Focus on atrial fibrillation patients with acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI)

Topic: Atrial Fibrillation, Other

Speaker: Professor M. Gilard (Brest, FR) Professor R. Lopes (Durham, US)

Sponsored by The Bristol-Myers Squibb/Pfizer Alliance

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speakers

Professor Martine Gilard

Hospital Cavale Blanche, Brest (France)

23 presentations

7 followers

Professor Renato Lopes

Duke University Medical Center, Durham (United States of America)

24 presentations

0 follower

4 more presentations in this session

Achievements with NOACs in NVAF to date

Speaker: Professor M. Gilard (Brest, FR)

Access

Slides

Video

NOACs in atrial fibrillation: Current landscape in clinical practice

Speaker: Professor N. Danchin (Paris, FR)

Access

Slides

Video

Exploring evidence for long-standing questions

Speaker: Professor R. Lopes (Durham, US)

Access

Slides

Video

Management of atrial fibrillation patients with concomitant need for antiplatelet therapy: Is the dilemma resolved?

Speaker: Professor P. Sinnaeve (Leuven, BE)

Access

Slides

Video

Access the full session

Improving outcomes with non-vitamin K antagonist oral anticoagulants (NOACs): Focus on atrial fibrillation patients with acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI)

Speakers: Professor M. Gilard, Professor R. Lopes, Professor M. Gilard, Professor N. Danchin, Professor R. Lopes...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources